Based on the Pulmatrix Inc stock forecast from 0 analysts, the average analyst target price for Pulmatrix Inc is not available over the next 12 months. Pulmatrix Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Pulmatrix Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Pulmatrix Inc’s stock price was USD 8.11. Pulmatrix Inc’s stock price has changed by +6.29% over the past week, +10.79% over the past month and +355.62% over the last year.
No recent analyst target price found for Pulmatrix Inc
No recent average analyst rating found for Pulmatrix Inc
Company Overview Pulmatrix Inc
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts. Read Less
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery p...Read More
Frequently Asked Questions About Pulmatrix Inc (PULM) Stock
Stock Target Advisor's fundamental analysis for Pulmatrix Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on PULM's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on PULM's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on PULM's stock to indicate if its overvalued.
The last closing price of PULM's stock was USD 8.11.
The most recent market capitalization for PULM is USD 0.03B.
Unfortunately we do not have enough analyst data on PULM's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pulmatrix Inc's stock.
As per our most recent records Pulmatrix Inc has 22 Employees.
Pulmatrix Inc's registered address is 36 Crosby Drive, Bedford, MA, United States, 01730.
You can get more information about it from Pulmatrix Inc's website at https://www.pulmatrix.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Pulmatrix Inc (PULM) Stock
Stock Target Advisor's fundamental analysis for Pulmatrix Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on PULM's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on PULM's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on PULM's stock to indicate if its overvalued.
The last closing price of PULM's stock was USD 8.11.
The most recent market capitalization for PULM is USD 0.03B.
Unfortunately we do not have enough analyst data on PULM's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pulmatrix Inc's stock.
As per our most recent records Pulmatrix Inc has 22 Employees.
Pulmatrix Inc's registered address is 36 Crosby Drive, Bedford, MA, United States, 01730.
You can get more information about it from Pulmatrix Inc's website at https://www.pulmatrix.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PULM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
